How does Leuprolide therapy impact bone health, including its effects on bone density, fracture risk, and the need for concurrent treatment to prevent osteoporosis?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Leuprolide can reduce bone density, increasing fracture risk. Patients may need supplements or treatment to mitigate osteoporosis risk.
Leuprolide, a GnRH agonist, lowers estrogen and testosterone, increasing osteoporosis risk. It may reduce bone density and heighten fracture risk, often necessitating osteoporosis prevention treatments alongside.